UBS O'Connor’s Kindred Biosciences KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-100,000
Closed -$1.06M – 348
2018
Q2
$1.06M Buy
+100,000
New +$975K 0.02% 205
2014
Q4
– Sell
-98,295
Closed -$909K – 739
2014
Q3
$909K Buy
+98,295
New +$1.33M 0.02% 354

Other funds holding KIN

UBS O'Connor's KIN Position: Q3 2018 in Review

UBS O'Connor sold out of Kindred Biosciences (KIN) in Q3 2018, closing a stake of 100,000 shares — an estimated $1.06M sold.

UBS O'Connor first reported a position in KIN in Q3 2014 and held it in 2 quarters. The position peaked at $1.06M in Q2 2018. 81 funds tracked by Wall St. Rank hold KIN as of Q3 2018.

  • UBS O'Connor reported no remaining Kindred Biosciences position as of Q3 2018 after selling out during the quarter.
  • UBS O'Connor sold 100,000 Kindred Biosciences shares in Q3 2018, an estimated $1.06M.
  • UBS O'Connor first reported a position in Kindred Biosciences in Q3 2014 and held it in 2 quarters.
  • UBS O'Connor's Kindred Biosciences position peaked at $1.06M in Q2 2018.
  • 81 funds tracked by Wall St. Rank held Kindred Biosciences as of Q3 2018.

Based on UBS O'Connor's 13F filing for Q3 2018, filed 14 Nov 2018.